1. Home
  2. MGX vs LVO Comparison

MGX vs LVO Comparison

Compare MGX & LVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGX
  • LVO
  • Stock Information
  • Founded
  • MGX 2018
  • LVO 2009
  • Country
  • MGX United States
  • LVO United States
  • Employees
  • MGX N/A
  • LVO N/A
  • Industry
  • MGX
  • LVO Restaurants
  • Sector
  • MGX
  • LVO Consumer Discretionary
  • Exchange
  • MGX NYSE
  • LVO Nasdaq
  • Market Cap
  • MGX 62.1M
  • LVO 61.3M
  • IPO Year
  • MGX 2024
  • LVO N/A
  • Fundamental
  • Price
  • MGX $1.45
  • LVO $0.72
  • Analyst Decision
  • MGX Strong Buy
  • LVO Strong Buy
  • Analyst Count
  • MGX 4
  • LVO 1
  • Target Price
  • MGX $13.00
  • LVO $1.50
  • AVG Volume (30 Days)
  • MGX 417.1K
  • LVO 337.0K
  • Earning Date
  • MGX 08-13-2025
  • LVO 06-18-2025
  • Dividend Yield
  • MGX N/A
  • LVO N/A
  • EPS Growth
  • MGX N/A
  • LVO N/A
  • EPS
  • MGX N/A
  • LVO N/A
  • Revenue
  • MGX $45,263,000.00
  • LVO $114,405,000.00
  • Revenue This Year
  • MGX N/A
  • LVO N/A
  • Revenue Next Year
  • MGX $11.75
  • LVO N/A
  • P/E Ratio
  • MGX N/A
  • LVO N/A
  • Revenue Growth
  • MGX N/A
  • LVO N/A
  • 52 Week Low
  • MGX $1.23
  • LVO $0.55
  • 52 Week High
  • MGX $5.50
  • LVO $1.82
  • Technical
  • Relative Strength Index (RSI)
  • MGX 40.18
  • LVO 42.30
  • Support Level
  • MGX $1.41
  • LVO $0.77
  • Resistance Level
  • MGX $1.59
  • LVO $0.92
  • Average True Range (ATR)
  • MGX 0.13
  • LVO 0.08
  • MACD
  • MGX -0.02
  • LVO -0.01
  • Stochastic Oscillator
  • MGX 11.32
  • LVO 12.22

About MGX METAGENOMI INC

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.

About LVO LiveOne Inc.

LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.

Share on Social Networks: